Recent Company News

• 02:47 AM ET Sep 15, 2026
  

  StreetAccount Summary - European pre-market trading update

• 07:39 PM ET Sep 14, 2026
  

  SCHOTT Pharma initiated overweight at JPMorgan (€22.60, 0.00)

• 06:38 AM ET Aug 18, 2026
  

  Tech, miners, industrials and financials the biggest laggards; retail, media, energy the best performers:

• 11:50 PM ET Aug 17, 2026
  

  SCHOTT Pharma upgraded to overweight from equal weight at Barclays (€21.60, 0.00)

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Themes

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Guidance

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Q&A

• 01:10 AM ET Aug 12, 2026
  

  SCHOTT Pharma reports Q3 EPS €0.26 vs FactSet €0.26 [4 est, €0.26-0.27]; confirms FY26 forecast (€22.40, 0.00)

• 05:27 PM ET Jul 09, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:56 AM ET Jul 09, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market